Cardinal Health, Inc. (NYSE:CAH – Free Report) – Equities research analysts at Leerink Partnrs lowered their Q1 2025 earnings estimates for shares of Cardinal Health in a report issued on Monday, April 22nd. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $1.73 per share for the quarter, down from their previous estimate of $1.83. Leerink Partnrs has a “Outperform” rating on the stock. The consensus estimate for Cardinal Health’s current full-year earnings is $7.28 per share. Leerink Partnrs also issued estimates for Cardinal Health’s Q2 2025 earnings at $1.84 EPS, Q3 2025 earnings at $2.14 EPS, Q4 2025 earnings at $1.96 EPS and FY2025 earnings at $7.67 EPS.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its earnings results on Thursday, February 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.26. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The company had revenue of $57.45 billion for the quarter, compared to the consensus estimate of $57.02 billion. During the same quarter last year, the company earned $1.32 EPS. The firm’s quarterly revenue was up 11.6% on a year-over-year basis.
Check Out Our Latest Stock Report on CAH
Cardinal Health Stock Performance
CAH stock opened at $103.54 on Tuesday. The company has a market capitalization of $25.18 billion, a PE ratio of 40.76, a price-to-earnings-growth ratio of 0.99 and a beta of 0.68. The company’s fifty day moving average price is $109.56 and its 200-day moving average price is $104.59. Cardinal Health has a one year low of $77.56 and a one year high of $116.04.
Institutional Investors Weigh In On Cardinal Health
A number of institutional investors and hedge funds have recently bought and sold shares of CAH. Clearstead Trust LLC purchased a new position in shares of Cardinal Health during the fourth quarter valued at $25,000. Cornerstone Planning Group LLC bought a new stake in shares of Cardinal Health in the 3rd quarter valued at about $26,000. Raleigh Capital Management Inc. lifted its position in shares of Cardinal Health by 4,466.7% in the 4th quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock worth $28,000 after purchasing an additional 268 shares during the period. BKM Wealth Management LLC bought a new position in shares of Cardinal Health during the fourth quarter valued at approximately $30,000. Finally, Hexagon Capital Partners LLC raised its stake in Cardinal Health by 53.6% in the fourth quarter. Hexagon Capital Partners LLC now owns 338 shares of the company’s stock worth $34,000 after buying an additional 118 shares in the last quarter. 87.17% of the stock is owned by institutional investors.
Cardinal Health Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were issued a $0.5006 dividend. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.93%. Cardinal Health’s payout ratio is 78.74%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories
- Five stocks we like better than Cardinal Health
- What is MarketRank™? How to Use it
- High-Yield Texas Instruments Could Hit New Highs Soon
- How to Calculate Stock Profit
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Invest in the FAANG Stocks
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.